News Category
The American Heart Association funds a Cedars-Sinai team to develop an AI-powered early warning system that could identify rising cardiac arrest risk ...
SeABank's Sustainable Finance Framework, backed by an S&P Global Ratings second-party opinion, creates a unified structure to mobilize capital for gre...
Enodia Therapeutics has named Henrik Torp Nielsen as Chief Financial Officer, bringing nearly two decades of biopharma finance experience to guide the...
Certified-PEP has published a 100-point comparison of 10 research peptide suppliers, drawing attention to inconsistencies in Certificates of Analysis,...
A retrospective on Dr. Leonard Hochstein's 30-year plastic surgery career underscores the importance of listening and precision in patient care, as re...
Creative Biolabs is spotlighting three-dimensional tumor organoid and immune cell co-culture services that let preclinical researchers study CAR-T act...
Creative Biolabs' new dual-vesicle platform combines OMV and exosome engineering to help researchers overcome CAR-T infiltration, persistence, and saf...
GeoVax's $1 million revolving loan from Bowery Consulting Group comes with significant governance changes, as the lender nominates three new directors...
Bronwyn Brophy O'Connor will become CEO of Carl Zeiss Meditec on December 1, 2026, bringing extensive medtech experience to drive innovation and trans...
Viromed Medical AG raised approximately EUR 2 million through a capital increase to finance working capital, strengthening its financial position as i...
PolyPeptide shareholders approved a new board and the removal of transfer restrictions, contingent on Samsung Biologics' tender offer, marking a pivot...
SS Innovations International showcased its SSi Mantra system and MantrAsana console in successful telesurgeries spanning 7,500 miles, highlighting the...
HeartBeam's acceptance into the FDA's TAP Pilot Program could significantly accelerate the development and regulatory review of its 3D ECG technology ...
SS Innovations International showcased its SSi Mantra system and MantrAsana console in successful remote surgeries across 7,500 miles, highlighting th...
TransCode Therapeutics' TTX-MC138 met its primary safety endpoint in a Phase 1a trial, with no dose-limiting toxicities and early signs of disease sta...
Oncotelic Therapeutics has published a peer-reviewed study showing its PDAOAI platform identified a four-gene prognostic signature in hepatocellular c...
Tonix Pharmaceuticals will report third-quarter 2026 financial results on Nov. 9, 2026, providing investors with a key update on its commercial launch...
RC Medical's physician-first venture studio model, highlighted by CEO David Ferrera, builds standalone companies around clinical problems observed in ...
The American Heart Association's selection of five finalists for its 2026 Health Tech Competition highlights a strategic effort to accelerate adoption...
SS Innovations International has submitted its response to the FDA's request for additional information on its SSi Mantra surgical robotic system, mov...
NanoViricides has initiated a Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo virus in the DRC, a key step toward validating its broad-spe...
A UK study reveals that clearing immune fog can intercept lung cancer before diagnosis, potentially revolutionizing early treatment and saving lives.
NextPlat Corp opens a new PharmcoRx community pharmacy in Jacksonville, Florida, expanding its healthcare operations and advancing its strategy of com...
Scinai Immunotherapeutics' CDMO subsidiary signed a $5.1 million development and clinical manufacturing agreement with a Nasdaq-listed biopharmaceutic...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business moves its lead multiple sclerosis drug candidate, Lucid-MS, into a Phase...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to cut animal testing by up to 95% while accelerating preclinical...
SS Innovations is advancing telerobotic surgery with its SSi Mantra system, completing 195 remote procedures and expanding globally, while pursuing FD...
Lantern Pharma's regulatory and IRB approvals in Taiwan for Part 2 of its Phase 2 HARMONIC trial of LP-300 represent a key step in advancing a biomark...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to initiate a Phase 2 trial of Luci...
VERAXA Biotech's FDA-aligned New Approach Methodologies could significantly reduce animal testing and accelerate preclinical development of its antibo...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to initiate a Phase 2 trial of Lucid-MS, a nov...
XORTX Therapeutics is advancing XORLO, a proprietary oxypurinol formulation, toward an FDA new drug application as gout cases are expected to rise sig...
C60 Power's annual National C60 Day on October 9 underscores the commercial and scientific momentum behind Carbon 60, a molecule whose discovery earne...
C60 Power marks National C60 Day on October 9 with educational events and a storewide sale, aiming to raise awareness about carbon 60 and its potentia...
Quantum BioPharma's Study Start-Up Agreement with Thermo Fisher Scientific marks a crucial step toward launching a Phase 2 trial of Lucid-MS, a potent...
Telomir Pharmaceuticals' $5.6 million PIPE financing will fund the clinical development of Telomir-Zn, a potential first-in-class therapy for triple-n...
Earth Science Tech's Avenvi LLC real estate and asset management subsidiary is positioned to drive dependable revenue growth by supporting the company...
NanoViricides will present at the NIBA 153rd Investment Conference on October 7, 2026, highlighting its broad-spectrum antiviral NV-387, which is in P...
Quantum BioPharma's Study Start-Up Agreement with Thermo Fisher for its Lucid-MS Phase 2 trial marks a critical step toward developing a first-in-clas...
Gold prices extended their recovery on bargain buying, a weaker dollar, and falling Treasury yields, with softer U.S. economic data reducing expectati...
New research reveals that the skull may harbor a local immune system for the brain, potentially opening doors to novel treatments for brain diseases a...
The CDSCO's authorization of Okogen's EMERALD Phase 1/2 study for Treyegen (OKG-0303) pushes forward a novel single therapy designed to treat both vir...
Kairos Pharma's ENV-105 combined with apalutamide demonstrated a statistically significant improvement in progression-free survival for metastatic cas...
AXIM Biotechnologies has submitted a 510(k) to the FDA for a rapid, point-of-care tear lactoferrin test that could simplify and expand objective dry e...
GeoVax will present its next-generation MVA-X vaccine and continuous cell-line manufacturing platform at a major vaccine conference, potentially trans...
BFCH and NEXT10 are building UNLOCKD, a scalable health and wellness platform that could generate $65-$95 million in annual revenue and include 62 wel...
A new intraoperative test developed by the University of Nottingham and deployed by NHS England can identify a brain tumor's genetic makeup in about t...
NanoViricides has provided an update on its Phase II clinical trial of NV-387 Oral Gummies for Ebola, highlighting the potential of an oral antiviral ...
